SCHEMBL3997724

SCHEMBL3997724

CCOC(=O)CCN(Cc1ccccc1)CC(C(=O)OCC)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.42
PPARG P37231 1/20 0.40
ATM Q13315 1/20 0.40
LTA4H P09960 2/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HPGD P15428 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KCNH2 Q12809 1/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
SPPL2A Q8TCT8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3900842 0.89 ALOX5 (0.41) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL4481212 0.88 ALOX5 (0.47) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL3285667 0.82 ALOX5 (0.55) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL3002323 0.81 ALOX5 (0.47) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL513687 0.80 TDP1 (0.48) ALOX5LTA4HALDH1A1LMNAPOLB
SCHEMBL9332283 0.79 ALOX5 (0.49) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL1140947 0.78 SMN1; SMN2 (0.55) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL9324850 0.78 SMN1; SMN2 (0.55) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL5176893 0.75 BCHE (0.57) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA
SCHEMBL10392751 0.74 ALOX5 (0.47) ALOX5LTA4HSMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470816-B2 Nitrogen-containing heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-06-25 US disclosed
US-20090156572-A1 Nitrogen-containing heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-06-18 US disclosed
WO-2009072643-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156572-A1 Nitrogen-containing heterocyclic compound and use thereof NTSR2, NTSR1, HNMT ALOX5 756/4885PPARG 2364/4885ATM 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.